<DOC>
	<DOC>NCT00518453</DOC>
	<brief_summary>Due to antigenic changes of influenza viruses, the virus strains used in influenza vaccines are adjusted every year according to WHO and CPMP recommendations. Immunogenicity and tolerability of the newly composed vaccines are subject for evaluation in a yearly clinical trial in non-elderly adults and elderly subjects (CPMP/BWP/214/96).</brief_summary>
	<brief_title>Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy Subjects eligible for enrollment into this study are male and female adult volunteers Any serious disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Influenza vaccine</keyword>
</DOC>